Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Shares Issued (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Shares Issued for 7 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Sep 2025, up 101.35% year-over-year, with the annual reading at $9.4 million for FY2024, 674.94% up from the prior year.
  • Shares Issued hit -$1.9 million in Q4 2025 for IDEAYA Biosciences, down from $1.1 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $153.0 million in Q3 2023 to a low of -$152.4 million in Q4 2023.
  • Historically, Shares Issued has averaged $822588.2 across 5 years, with a median of $662000.0 in 2022.
  • Biggest YoY gain for Shares Issued was 43926.36% in 2023; the steepest drop was 15142.25% in 2023.
  • Year by year, Shares Issued stood at -$327000.0 in 2021, then surged by 409.79% to $1.0 million in 2022, then plummeted by 15142.25% to -$152.4 million in 2023, then soared by 101.22% to $1.9 million in 2024, then crashed by 203.77% to -$1.9 million in 2025.
  • Business Quant data shows Shares Issued for IDYA at -$1.9 million in Q4 2025, $1.1 million in Q3 2025, and -$314000.0 in Q2 2025.